中文 | English
Return
Total: 5 , 1/1
Show Home Prev Next End page: GO
Author:(ze Gong PENG)

1.Synthesis and evaluation for anti-HCoV-OC43 activity of novel aloperine derivatives with different core structures

Run-ze MENG ; Yue GONG ; Yu-long SHI ; Kun WANG ; Zong-gen PENG ; Dan-qing SONG

Acta Pharmaceutica Sinica 2024;58(2):404-412

2.Survey of type 1 diabetes incidence in children from 1997 to 2000 in Beijing area.

Chun-xiu GONG ; Cheng ZHU ; Chun YAN ; Jian-ping LIANG ; Gui-chen NI ; Jie GAO ; Yu-chuan LI ; Min LIU ; Xiao-xia PENG ; Ze YANG

Chinese Journal of Pediatrics 2004;42(2):113-116

3.Transarterial oily chemoembolization combined with interstitial laser thermotherapy for treatment of hepatocellular carcinoma.

Ze-jian ZHOU ; Rong-de XU ; Wei-ke LI ; Wen-xing ZHUANG ; Li-gong LU ; Pei-jian SHAO ; Xiao-ming CHEN ; Peng-fei LUO

Journal of Southern Medical University 2007;27(12):1866-1868

4.Effects of hepatitis B virus DNA mutation at 1762/1764 in the basic core promoter on metastasis or recurrence of hepatocellular carcinoma after hepalobectomy

wang Shu LIU ; fen Li ZHANG ; ping Li LIU ; sen Lin LIU ; Yue ZHANG ; Qi LI ; ze Gong PENG ; yun Shi BAO

Chinese Journal of Current Advances in General Surgery 2017;20(7):522-526

5.EST-SSR identification, markers development of Ligusticum chuanxiong based on Ligusticum chuanxiong transcriptome sequences.

Can YUAN ; Fang PENG ; Ze-Mao YANG ; Wen-Juan ZHONG ; Fang-Sheng MOU ; Yi-Yun GONG ; Pei-Cheng JI ; De-Qiang PU ; Hai-Yan HUANG ; Xiao YANG ; Chao ZHANG

China Journal of Chinese Materia Medica 2017;42(17):3332-3340

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 5 , 1/1 Show Home Prev Next End page: GO